322 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2900

Harbin Medisan Pharmaceutical
CN¥10.13-4.1%-21.9%CN¥3.1bn/aPE58.8xn/a1.0%

688373

Shanghai MicuRx Pharmaceutical
CN¥4.71-9.2%-48.5%CN¥3.1bCN¥8.55PS29xE-0.2%n/a

300006

Chongqing Lummy Pharmaceutical
CN¥2.92-2.7%-20.2%CN¥3.1bn/aPS3.6xn/a0%

2412

Hunan Hansen Pharmaceutical
CN¥6.163.5%-9.1%CN¥3.0bn/aPE14.9xn/a4.9%

300404

Boji Medical TechnologyLtd
CN¥7.99-1.0%-16.7%CN¥3.0bCN¥11.74PE104.1xE63.7%0.1%

504

Landfar Bio-medicine
CN¥8.293.4%-23.9%CN¥3.0bn/aPS21.4xn/an/a

300238

Guanhao BiotechLtd
CN¥11.275.6%-18.9%CN¥3.0bn/aPE128.4xn/a0%

300452

Anhui Sunhere Pharmaceutical ExcipientsLtd
CN¥13.540.4%-23.6%CN¥3.0bCN¥18.00PE19.4xE18.0%1.8%

603538

Ningbo Menovo Pharmaceutical
CN¥13.98-5.0%-32.1%CN¥3.0bn/aPS2.4xE96.7%1.2%

605177

Zhejiang East Asia Pharmaceutical
CN¥26.70-3.3%22.4%CN¥3.0bn/aPE24.4xn/a1.2%

300813

Zhejiang Tailin BioEngineeringLtd
CN¥23.9428.4%-15.6%CN¥3.0bn/aPE326.7xn/a0.4%

301281

Shandong Keyuan Pharmaceutical
CN¥27.16-6.2%-1.7%CN¥3.0bn/aPE44.2xn/a1.1%

600222

Henan Taloph Pharmaceutical StockLtd
CN¥5.271.0%-11.9%CN¥3.0bn/aPE48.2xn/a0%

153

Anhui Fengyuan Pharmaceutical
CN¥8.84-0.6%-12.6%CN¥2.9bn/aPE18.3xn/a1.7%

300436

Fujian Cosunter Pharmaceutical
CN¥18.26-1.5%-38.9%CN¥2.9bn/aPS6.4xn/a0%

2107

Shandong Wohua Pharmaceutical
CN¥4.96-1.2%-22.9%CN¥2.8bn/aPE66.6xn/a5.0%

300583

Shandong Sito Bio-technology
CN¥14.72-9.5%-7.3%CN¥2.8bn/aPE83.8xE28.9%0.06%

300147

Xiangxue PharmaceuticalLtd
CN¥4.188.3%-23.4%CN¥2.8bn/aPS1.2xn/a0%

301331

Enwei Pharmaceutical
CN¥41.700.9%-5.9%CN¥2.8bn/aPE43.6xn/a3.8%

518

Jiangsu Sihuan Bioengineering
CN¥2.547.6%-8.3%CN¥2.7bn/aPS11.1xn/an/a

600513

Jiangsu Lianhuan Pharmaceutical
CN¥9.68-0.1%-2.1%CN¥2.7bn/aPE20.3xn/a1.5%

600624

Shanghai Fudan Forward S&T
CN¥4.06-3.6%-31.1%CN¥2.7bn/aPS4.1xn/a0%

301257

SMO ClinPlusLTD
CN¥45.33-3.0%-38.2%CN¥2.7bn/aPE21xE18.7%0.3%

688137

Novoprotein Scientific
CN¥38.08-5.0%-31.9%CN¥2.7bn/aPS19.6xn/a1.3%
Page 11 of 14
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.